Terumo Corporation (TUO.F)

15,60 +0,20 (+1,30%) Alla chiusura: 08:10AM CEST

Terumo Corporation

2-44-1, Hatagaya
Shibuya-ku
Tokyo 151-0072
Japan
81 3 3374 8111
https://www.terumo.com

Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 30.207

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Shinjiro Sato	Corporate Advisor & Director	734,12k	N/D	1960
Mr. Hikaru Samejima	President, CEO & Director	N/D	N/D	1964
Jin Hagimoto	CFO, CIO, GM of CFO Office, Controller & Treasury Tax Dept., J-SOX Office, IT Planning Dept. & GBS	N/D	N/D	N/D
Shinji Omori	CTO, GM of DX Promotion Dept. R&D Division and Executive Officer	N/D	N/D	N/D
Ms. Miho Mizuguchi	Executive Officer, Chief Legal Officer and GM of CLO Office, Legal & Compliance Department	N/D	N/D	N/D
Tomoko Adachi	Chief Human Resources Officer & Group Executive Officer	N/D	N/D	N/D
Mr. Shoji Hatano	Director & Corporate Advisor	N/D	N/D	1959
James Rushworth	Group Executive Officer & Chief Commercial Officer	N/D	N/D	N/D
Mr. Kazunori Hirose	Director & Group Managing Executive Officer	N/D	N/D	1964
Itaru Sakaguchi	Group Managing Executive Officer	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Governance aziendale

L'ISS Governance QualityScore di Terumo Corporation al 1 maggio 2024 è 6. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 5; diritti degli azionisti: 3; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.